|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.600 USD | -13.33% |
|
+46.89% | - |
| 20/07 | Nine stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 17/07 | 19 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 52Cr 5.48Cr 4.75Cr 4.44Cr 4.06Cr 7.64Cr 523Cr 7.76Cr 20Cr 261.64Cr 21Cr 20Cr 871.42Cr | P/E 2026 * |
-1.42x | P/E 2027 * | -2.05x |
|---|---|---|---|---|---|
| Enterprise Value | 42Cr 4.38Cr 3.79Cr 3.54Cr 3.24Cr 6.1Cr 417.46Cr 6.2Cr 16Cr 208.85Cr 16Cr 16Cr 695.57Cr | EV / Sales 2026 * |
21.9x | EV / Sales 2027 * | 13.7x |
| Free-Float |
70.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Orexo AB
| 1 day | -13.33% | ||
| 1 week | +46.89% | ||
| Current month | +46.89% | ||
| 1 month | +30.00% | ||
| 3 months | +27.14% |
| 1 month | 1.36 |  | 2.6 |
| Current year | 1.36 | | 2.65 |
| 1 year | 1.36 | | 4.05 |
| 3 years | 0.89 | | 4.05 |
| 5 years | 0.76 | | 4.05 |
| 10 years | 0.76 | | 9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikolaj Sørensen
CEO | Chief Executive Officer | 54 | 05/02/2013 |
Fredrik Järrsten
DFI | Director of Finance/CFO | 59 | 01/09/2022 |
Jonas Savmarker
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 01/01/2002 | |
George Wilkinson
BRD | Director/Board Member | 70 | 11/04/2019 |
Christine Rankin
BRD | Director/Board Member | 62 | 01/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.33% | +46.89% | - | - | 5.48Cr | |
| +1.82% | +2.47% | +62.25% | +24.01% | 32TCr | |
| -1.31% | -2.66% | +31.90% | -12.77% | 7.21TCr | |
| -0.48% | +24.74% | +63.15% | +133.07% | 1.16TCr | |
| +0.63% | +1.87% | -3.74% | -3.95% | 844.3Cr | |
| +3.86% | +13.14% | -10.94% | -11.03% | 489.91Cr | |
| -0.47% | +24.45% | +3.76% | +50.57% | 435.76Cr | |
| +1.74% | +11.41% | -26.79% | +12.70% | 431.22Cr | |
| -1.20% | +2.33% | +14.16% | +48.07% | 273.6Cr | |
| +0.80% | +0.63% | +1.98% | -0.53% | 227.46Cr | |
| Average | -0.98% | +328.87% | +15.08% | +26.68% | 4.82TCr | |
| Weighted average by Cap. | -0.24% | +171.96% | +53.03% | +20.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.9Cr 20.02L 17.33L 16.2L 14.81L 27.91L 19Cr 28.34L 74.55L 9.55Cr 75.19L 73.55L 32Cr | 2.75Cr 28.98L 25.09L 23.45L 21.43L 40.39L 28Cr 41.02L 1.08Cr 14Cr 1.09Cr 1.06Cr 46Cr |
| Net income | -38Cr -3.95Cr -3.42Cr -3.2Cr -2.92Cr -5.51Cr -376.92Cr -5.59Cr -15Cr -188.57Cr -15Cr -15Cr -628.03Cr | -27Cr -2.85Cr -2.47Cr -2.31Cr -2.11Cr -3.97Cr -271.89Cr -4.03Cr -11Cr -136.02Cr -11Cr -10Cr -453.02Cr |
| Net Debt | -10Cr -1.11Cr -95.8L -89.54L -81.84L -1.54Cr -105.54Cr -1.57Cr -4.12Cr -53Cr -4.16Cr -4.06Cr -175.85Cr | -14Cr -1.51Cr -1.3Cr -1.22Cr -1.11Cr -2.1Cr -143.73Cr -2.13Cr -5.61Cr -72Cr -5.66Cr -5.54Cr -239.49Cr |
Employees
61
Sector
Pharmaceuticals
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORX Stock
- ORXOY Stock
Select your edition
All financial news and data tailored to specific country editions
